Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Little Green Pharma.
RELATED STOCKHEAD STORIES
News
ASX Small Caps Lunch Wrap: Markets higher yada yada… Germans legalise Pot!
Health & Biotech
ASX Health Stocks: Singular Health shoots 60pc through the roof after breakthrough deal in US
Health & Biotech
Weed Week: Cannabis stocks down almost 20pc in 2023, but here’s why they could rebound by Q2 2024
Health & Biotech
ASX Health Stocks: Imagion and Microba’s positive Phase 1 results; and LGP’s first mover advantage in France
Health & Biotech
Weed Week: Cannabis boom a ‘matter of when, not if’; and NSW to allow residents to grow pot
Health & Biotech
Weed Week: Mastercard says NO to cannabis transactions, as New York becomes the happening place for weed
Health & Biotech
How Bod Science pulled ahead in the race for Australia’s first over-the-counter CBD
Health & Biotech
ASX Health Stocks: Cannabis stock Little Green Pharma awarded French trial tender for CBD50
News
Market Highlights: ASX to rise again; PwC predicts one in six fundies will vanish by 2027
Health & Biotech
Weed Week: A ‘shroom boom’ could see psychedelics follow cannabis’ explosive footsteps
Health & Biotech
Weed Week: Cannabis helps chronic pain and insomnia, and here’s what the TGA rules say
Health & Biotech
ASX Health Stocks: Little Green Pharma gets French deal extension; FDA approves Immuron trial
Health & Biotech
Weed Week: New studies confirm cannabis alleviates cancer pain, cuts need for opioids, and improves sleep
Health & Biotech
Could these Aussie psychedelics stocks carve a slice out of a ‘potential $63 billion’ global market?
Health & Biotech
Weed Week: Most Aussies still use illicit cannabis, but more are now turning to prescriptions
News
Banking on pot: Minus one global investment house, Switzerland moves to legalise cannabis
News
